Tuesday, January 6, 2015

Top 5 US Companies To Buy Right Now

NEW YORK (TheStreet) -- The oft-rumored Apple (AAPL) iWatch gets as much attention from the media, Wall Street and consumers as products that actually exist, and one analyst noted the iWatch will be more than just something to pair with an iPhone.

Cantor Fitzgerald analyst Brian White, he of the $777 price target, wrote in a research report that the iWatch may actually do more than people think. Citing an Apple supplier, White noted the device could allow consumers to control their home.

"As an Apple supplier, our contact offered insight into the "iWatch" and described this potential new device as much more than an extension of your iPhone but as a multi-purpose gateway in allowing consumers to control their home (i.e., heating/cooling, lights, audio, video, etc.)," White wrote in the report.

Top Solar Companies For 2015: Visteon Corporation(VC)

Visteon Corporation supplies automotive systems, modules, and components to automotive original equipment manufacturers worldwide. The company offers a range of electronics products, including audio/infotainment systems and components, such as base radio/CD head units, infotainment head units, audiophile systems and amplifiers, rear seat family entertainment systems, digital and satellite radios, HD and DAB broadcast tuners, MACH voice link technology, and connectivity solutions for portable devices; driver information systems comprising instrument clusters and displays to assist driving; and powertrain and feature control modules, including controllers for fuel pumps, transfer cases, tuning valves, and security and voltage regulation systems. It also provides electronic climate controls, such as single zone manual electronic and automatic multiple zone modules, as well as integrated audio and climate control assemblies; and lighting products consisting of headlamps, stop lamps, and fog lamps. In addition, the company offers integrated heating, ventilation, and air conditioning systems, which include evaporators, condensers, heater cores, climate controls, compressors, air handling cases, and fluid transport systems; and components and modules that provide cooling and thermal management for the vehicle?s engine and transmission, as well as for batteries and power electronics on hybrid and electric vehicles. Further, it provides interior products, including cockpit modules, which incorporate structural, electronic, climate control, mechanical, and safety components; door panels/modules and interior trim products; and console modules, which deliver storage options. The company was founded in 2000 and is headquartered in Van Buren Township, Michigan.

Advisors' Opinion:
  • [By Seth Jayson]

    Visteon (NYSE: VC  ) reported earnings on May 9. Here are the numbers you need to know.

    The 10-second takeaway
    For the quarter ended March 31 (Q1), Visteon beat expectations on revenues and crushed expectations on earnings per share.

  • [By David Sterman]

    Auto parts maker Visteon (NYSE: VC) clearly embodies the new thinking about share buybacks. The company announced plans last month to sell its $1.5 billion stake in a joint venture with a Chinese partner. Visteon could have looked to pay down debt or make an acquisition, or simply keep the ($1.2 billion after-tax) proceeds. Instead, almost all of the money will go toward a share buyback that might reduce shares outstanding by 25%.

Top 5 US Companies To Buy Right Now: Etfs Gold Trust (SGOL)

ETFS Gold Trust (the Trust) is an investment trust. The investment objective of the Trust is for the Shares to reflect the performance of the price of gold bullion, less the expenses of the Trust�� operations. The Trust holds gold bullion and issues ETFS Physical Swiss Gold Shares (the Shares) in exchange for deposits of gold and distributes gold in connection with redemption of Baskets. The sponsor of the Trust is ETF Securities USA LLC (the Sponsor). The trustee of the Trust is The Bank of New York Mellon and the custodian is JP Morgan Chase Bank N.A. Advisors' Opinion:
  • [By Peter Pham]

    Although the Fed doubled its bond buying last September, the top gold exchange-traded funds, or ETFs, including SPDR Gold Shares (NYSEMKT: GLD  ) , iShares Gold Trust (NYSEMKT: IAU  ) , and ETFS Physical Swiss Gold Shares (NYSEMKT: SGOL  ) , have dropped around 25% each over the last 12 months, which speaks to gold's extreme vulnerability to QE tapering. Even the mere mention of tapering seems to send gold into a tailspin, as seen with SPDR Gold Shares, which has plunged 24% year to date and also suffered massive losses with its physical holdings. Market Vectors Gold Miners ETF (NYSEMKT: GDX  ) has suffered a massive drop of 48% so far in 2013, making it one of the worst-performing ETFs this year.

Top 5 US Companies To Buy Right Now: Amgen Inc.(AMGN)

Amgen Inc., a biotechnology medicines company, discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology for grievous illnesses primarily in the United States, Europe, and Canada. The company markets recombinant protein therapeutics in supportive cancer care, nephrology, and inflammation. Its principal products include Aranesp and EPOGEN erythropoietic-stimulating agents that stimulate the production of red blood cells; Neulasta and NEUPOGEN to stimulate the production of neutrophils, which is a type of white blood cell that helps the body to fight infections; and Enbrel, an inhibitor of tumor necrosis factor that plays a role in the body?s response to inflammatory diseases. The company also markets other products comprising Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin (TPO) receptor agonist that mimics endogenous TPO, the primary driver of platelet production. In addition, it provides Denosumab, a human monoclonal antibody that targets RANKL, an essential regulator of osteoclasts. Further, the company offers product candidates in mid-to-late stage development in a variety of therapeutic areas, including oncology, hematology, inflammation, bone, nephrology, cardiovascular, and general medicine consisting of neurology. It markets its products to healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies; consumers; and wholesale distributors of pharmaceutical products. The company has various collaborative arrangements with Pfizer Inc.; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Daiichi Sankyo Company, Limited; Array BioPharma Inc.; Kyowa Hakko Kirin Co. Ltd.; and Cytokinetics, Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.

Advisors' Opinion:
  • [By Nicholas Vardy]

    It's very much weighted toward some of the bigger stocks in the sector—Gilead Sciences (GILD), Amgen (AMGN), Biogen (BIIB), Celgene Corporation (CELG), Onyx (ONXX), which just received an unsolicited $10 billion bid, just in the past few weeks, and that would be really the best way to minimize your specific or company risk.

  • [By Dan Carroll]

    Amgen on the acquisition trail
    Big biotech superstar Amgen (NASDAQ: AMGN  ) didn't have the best week in biotech, but it still made investors happy, as shares gained nearly 5% over the past five days. Amgen's hardly the kind of boom-or-bust stock that exemplifies this risk-fraught sector, but even this relatively stable pick can make waves. It's rumored to be one of the contenders looking to acquire fellow biotech star stock Onyx Pharmaceuticals (NASDAQ: ONXX  ) , according to sources in a report from Reuters released this week.

Top 5 US Companies To Buy Right Now: Ishares S&P 500 (IVV)

iShares Core S&P 500 ETF, formerly iShares S&P 500 Index Fund (the Fund) seeks investment results that correspond generally to the price and yield performance of United States large-cap stocks, as represented by the Standard & Poor�� 500 Index (the Index). The Index measures the performance of the large-capitalization sector of the United States equity market. The Index serves as the underlying index for the S&P 500/Citigroup Growth and Value Index series.

The Index is a capitalization-weighted index from a range of industries chosen for market size, liquidity and industry group representation. The component stocks are weighted according to the total float-adjusted market value of their outstanding shares. The Index is adjusted to reflect changes in capitalization resulting from mergers, acquisitions, stock rights, substitutions and other capital events. The Fund�� investment advisor is Barclays Global Fund Advisor.

Advisors' Opinion:
  • [By Dan Caplinger]

    Much smaller is the iShares Core S&P 500 ETF (NYSEMKT: IVV  ) . With about $43 billion under management, the iShares ETF comes with lower expenses of 0.07%, but much lower average daily volume of just 3.8 million shares. Like the Spiders, its share price roughly corresponds to a tenth of the value of the S&P 500 index.

  • [By John Udovich]

    One of the most famous scenes in the cult classic, the Graduate, was when Mr. McGuire�took Dustin Hoffman�� character aside and said�"Ben, I want to say one word to you, just one word: Plastics"; but what about the Berry Plastics Group Inc (NYSE: BERY) and its performance verses that of the�iShares S&P 500 Index ETF (NYSEARCA: IVV), iShares Russell Midcap Index Fund ETF (NYSEARCA: IWR) and iShares S&P SmallCap 600 Index ETF (NYSEARCA: IJR)? I should mention that plastics and the Berry Plastics Group was not the place to be yesterday as the stock took a tumble on reduced guidance.

No comments:

Post a Comment